KDM1A and cancer: Interestingly though, a survey of the anti-tumor activity of SP2509 reported that SP2509 could inhibit JAK/STAT3 signaling and related downstream gene expression dependent on its original target LSD1 in cancer cells [16], which in turn was tied to the innate immune response of the host cell.